Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Samsung Biologics obtains three global ISO certifications 2022-10-13 19:00
Guiyang's Wudang district shines in pharma sector 2022-10-13 10:12
Great Bay Bio Announces Official Launch of Site-Specific Integration Platform for Cell Line Development, AlfaCell® 2022-10-11 20:40
HanAll's Licensed Partner in China Enters Sublicense Agreement with CSPC to Further Accelerate Development of Batoclimab 2022-10-11 19:00
Samsung Biologics unlocks additional capacity for production at its newest Plant 4 2022-10-11 19:00
IASO Biotherapeutics and Cabaletta Bio Announce Exclusive Worldwide License Agreement for Clinically Validated CD19 Binder 2022-10-11 19:00
Antengene Announces Upcoming Presentations at the 2022 Society for Immunotherapy of Cancer Annual Meeting 2022-10-08 10:43
First patient treated in Clarity's therapeutic prostate cancer trial 2022-10-07 21:06
HanAll's Second FcRn Inhibitor HL161ANS to be Added to the Development Program of its Licensed Partner 2022-10-04 19:00
Hayashibara Brings Back "Trehalose Symposium" to Reveal Its Game-changing Versatilities in Human Biochemistry 2022-10-04 14:00
AeroRx Partners with HCmed to Develop a Nebulized LABA/LAMA Combination Solution for the Treatment of Chronic Obstructive Pulmonary Disease 2022-10-03 09:00
Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2022 2022-10-01 04:30
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022 2022-09-29 19:00
NeuShen Therapeutics Closes Pre-A Financing with ~$20M 2022-09-29 17:50
Kintor Pharma Announces Publication of Phase Ib Data from Pruxelutamide for AR+ mBC in EJC 2022-09-29 14:22
Simcere and Almirall Enter into a Licensing Agreement for IL-2 mu-Fc 2022-09-29 11:32
Zhongchao Inc. Establishes Chongqing Xinjiang Pharmaceutical Co., Ltd. to Improve Patient Access to Medications 2022-09-28 21:18
Samsung Biologics Earns Gold Rating from EcoVadis for Its Sustainability Efforts 2022-09-28 19:00
Harbour BioMed Announces First Subject Dosed in Phase I Study of Next-Gen Anti-TSLP Fully Human Monoclonal Antibody 2022-09-27 21:40
Angel Pharmaceuticals Announces Approval of IND Application for Phase 1/1b Clinical Trial of Mupadolimab (Anti-CD73) in China 2022-09-27 08:30
1 49 50 51 52 53 148